Similar to these findings in various tumors, in this study too, we found that NUSAP1 was dramatically overexpressed in advanced stage astrocytoma patients; moreover, overexpression of NUSAP1 was also predictive of poor overall survival. Here, NUSAP1 is linked to astrocytoma (excluding glioblastoma).